Creative Medical Technology Holdings Inc (CELZ)

[uvaphd]

Don’t you think they have a financial plan that will allow them to provide CaverStem kits to physicians right away? Why else would physicians—including world-renowned urologists—risk their professional reputations on something whose sustainability was even the slightest bit in question? Finally, don’t you think you might also want to know the price per kit before you rushed to the conclusion (based on what I have no idea) that the company is cash-starved in a way that will threaten its very viability? Dr. Thomas Ichim’s last venture was purchased for about $1.25/share—and that company was NOWHERE near commercialization, whereas CELZ is NOW—so you’ll have to forgive me for trusting his judgment over yours. I’ll sit back and wait for my payday.